Healing / Recovery · Research guide

KissPeptin-10 peptide: Healing / Recovery research guide

Catalogue reference · Laboratory research only

Not medical advice. KissPeptin-10 is sold for research. This guide does not recommend dosing, diagnosis, or therapy.

KissPeptin-10 is listed in our catalogue under “Healing / Recovery.” In scientific publications it is discussed in technical language; this page translates the general themes into everyday wording while staying faithful to research-only framing.

Plain-language snapshot

One-paragraph overview from our research datasheet—still scientific, but faster to read than the full mechanism list below.

Kisspeptin-10 decapeptide (Ki 2.33 nM at KISS1R) stimulates upstream hypothalamic GnRH release in natural pulsatile patterns for HPG axis neuroendocrine research.

What shows up in scientific writing (general background)

Many readers want context before diving into pathways. The list below summarises what researchers and reviewers discuss—cells, animals, and (for some drug-class molecules) formal clinical trials. It is not a promise of results for any individual.

“Reported” means described in the literature, not recommended for personal use. Our peptides are for laboratory research only.

Typical study contexts & reported directions

Rodent and cell models of tendon, muscle, ligament, or gut injury—scientists track repair markers, cell migration, and inflammatory readouts.
Wound-healing and angiogenesis assays where the question is how tissue responds after controlled damage.
Occasional case-style write-ups in research settings; these are not substitutes for clinical evidence.
Peer-reviewed preclinical work sometimes describes experiments that track whether binds KISS1R/GPR54 at Ki 2.33 nM with 8-fold higher affinity than full-length Kp-54 metastin
Peer-reviewed preclinical work sometimes describes experiments that track whether triggers PIP2 hydrolysis, Ca²⁺ mobilization, and ERK1/2/p38 MAPK phosphorylation in KISS1R-expressing neurons
Peer-reviewed preclinical work sometimes describes experiments that track whether stimulates endogenous GnRH release in natural pulsatile patterns — physiologically distinct from direct GnRH agonists
Peer-reviewed preclinical work sometimes describes experiments that track whether potent LH and FSH secretagogue via upstream hypothalamic HPG axis activation

Why Healing / Recovery research discusses this compound

Compounds in this family are frequently studied in models of tissue injury, wound closure, and how cells reorganise after damage. Research looks at cell movement, blood-vessel support, and inflammatory balance -not at replacing medical care.

Themes from preclinical literature (technical)

Below are mechanistic bullet points as they appear in our product reference material -useful for researchers comparing pathways. They are not simplified health claims.

Binds KISS1R/GPR54 at Ki 2.33 nM with 8-fold higher affinity than full-length Kp-54 metastin
Triggers PIP2 hydrolysis, Ca²⁺ mobilization, and ERK1/2/p38 MAPK phosphorylation in KISS1R-expressing neurons
Stimulates endogenous GnRH release in natural pulsatile patterns — physiologically distinct from direct GnRH agonists
Potent LH and FSH secretagogue via upstream hypothalamic HPG axis activation
Metastasis suppression activity through KISS1/GPR54 system inhibition of cell proliferation and migration
Enhances insulin secretion through pancreatic KISS1R signaling in metabolic research models

Typical handling notes (from our datasheet)

Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. ~5% degradation per year refrigerated. - see our storage guide for best practices on temperature, light, and shelf life.

Typical research dosing discussion (literature-style): 0.3-1.0 μg/kg IV bolus or 1.0-3.0 μg/kg SC · Single bolus or intermittent dosing; continuous infusion produces tachyphylaxis · Plasma t½ ~4 min (vs ~28 min for Kp-54). Complete clearance within 30 min post-bolus. Rapid degradation by circulating endopeptidases. Continuous infusion causes KISS1R desensitization with diminishing LH response (tachyphylaxis). Helical conformation at residues 4-10 is essential for receptor engagement.

For preparation, follow the step-by-step reconstitution guide and use the reconstitution calculator to confirm draw volumes. Review subcutaneous injection basics for technique, and always verify batch purity by reading the COA.

Frequently asked questions

What is KissPeptin-10 in plain language?
KissPeptin-10 is a research peptide we catalogue under “Healing / Recovery.” This article explains how scientists discuss it in published literature and what study types usually appear—not as a consumer product claim.

Does this page give medical advice or dosing instructions for KissPeptin-10?
No. Content is for laboratory and research literacy only. It does not diagnose, treat, or prevent disease, and is not a dosing guide.

Where can I see purity, variants, and pricing for KissPeptin-10?
Use the “View product” button to open the canonical shop listing for KissPeptin-10, where specifications and research SKU details are shown.

What about online case reports, before-and-after stories, or forum “logs” for KissPeptin-10?
Those sources are not peer-reviewed evidence. This guide focuses on preclinical literature and, where relevant, formal clinical trial programmes for drug-class molecules. Anecdotes may be interesting culturally; they are not a safe basis for dosing or medical decisions.

Need vial specs & pricing?

Open the shop listing for variants, purity notes, and research SKU details.

View product

Also known as: Kisspeptin-10, KP-10, Metastin(45-54), KISS1 Decapeptide, GPR54 Agonist, KISS1R Ligand, Kisspeptin C-Terminal Fragment